Sarepta Therapeutics, Inc. (Nasdaq: SRPT) to Ring The Nasdaq Stock Market Closing Bell

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. AXP
6. T
7. TMUS
8. CVS
9. UNH
10. SPY

Go back to Sarepta Therapeutics, Inc. (Nasdaq: SRPT) to Ring The Nasdaq Stock Market Closing Bell

UPDATE: Sarepta Therapeutics (SRPT) PT Raised to $55 at Piper Jaffray

September 6, 2017 10:57 AM EDT

(Updated - September 6, 2017 11:00 AM EDT)

(updated to add analyst comment)

Piper Jaffray raised its price target on Sarepta Therapeutics (NASDAQ: SRPT) to $55.00 (from $50.00) while maintaining a Overweight rating.

Analyst Edward Tenthoff notes the positive Exon 53 data. The analyst further comments... More

Sarepta (SRPT) SRP-4053 Data Strengthen Case for Exon Expansion Approach - Baird; Reit. OP, $101 PT

September 6, 2017 8:30 AM EDT

Baird analyst Brian Skorney reiterated an Outperform rating and $101 price target on Sarepta Therapeutics (NASDAQ: SRPT) following positive European Phase 1/2 study of SRP-4053.

Skorney said this strengthens the case for Sarepta's approach to exon expansion.

"With dystrophin expression exceeding that... More